LOS ANGELES--(BUSINESS WIRE)--Kernel, an innovator in non-invasive neuroimaging technology, announces the first patient has been measured in an observational study of depression treatments using ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A test-negative observational study design may be best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback